Table 5.
Medication use by category for 3-month pain symptom change trend improvers and non-improvers at the baseline and 8-week assessment.
| Baseline Assessment | 8-week Assessment | |||||
|---|---|---|---|---|---|---|
| Treatment | 3 month Improvers N=26 |
3 month Non-Improvers N=26 |
p-value | 3 month Improvers N=26 |
3 month Non-Improvers N=26 |
p-value |
| Alphablockers | 3 | 1 | 0.60 | 0 | 0 | 1.0 |
| Benzodiazepines | 1 | 1 | 1.0 | 0 | 0 | 1.0 |
| Anticholinergics | 1 | 2 | 1.0 | 0 | 1 | 1.0 |
| Elmiron | 1 | 2 | 1.0 | 0 | 0 | 1.0 |
| Gabapentinoids | 1 | 1 | 1.0 | 1 | 1 | 1.0 |
| Antihistamines | 0 | 1 | 1.0 | 0 | 0 | 1.0 |
| Bladder instillation | 1 | 1 | 1.0 | 0 | 0 | 1.0 |
| NSAIDs | 6 | 4 | 0.24 | 3 | 1 | 0.68 |
| Opioids | 2 | 4 | 0.66 | 1 | 0 | 1.0 |
| Pelvic floor physical therapy | 4 | 6 | 0.72 | 2 | 2 | 1.0 |
| NSRIs | 0 | 0 | 1.0 | 1 | 1 | 1.0 |
| SSRIs | 0 | 0 | 1.0 | 0 | 0 | 1.0 |
| Tricyclic antidepressants | 2 | 5 | 0.41 | 2 | 3 | 1.0 |
| Antibiotics/antifungals | 0 | 1 | 1.0 | 0 | 0 | 1.0 |